HomeCompareNTEC vs MCD

NTEC vs MCD: Dividend Comparison 2026

NTEC yields 20.77% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MCD wins by $2.0K in total portfolio value· pulled ahead in Year 10
10 years
NTEC
NTEC
● Live price
20.77%
Share price
$9.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$76.5K
Annual income
$7,308.86
Full NTEC calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — NTEC vs MCD

📍 MCD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNTECMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NTEC + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NTEC pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NTEC
Annual income on $10K today (after 15% tax)
$1,765.32/yr
After 10yr DRIP, annual income (after tax)
$6,212.53/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, MCD beats the other by $16,081.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NTEC + MCD for your $10,000?

NTEC: 50%MCD: 50%
100% MCD50/50100% NTEC
Portfolio after 10yr
$77.5K
Annual income
$16,768.28/yr
Blended yield
21.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

NTEC
Analyst Ratings
2
Buy
1
Hold
Consensus: Buy
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NTEC buys
0
MCD buys
0
No recent congressional trades found for NTEC or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNTECMCD
Forward yield20.77%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$76.5K$78.5K
Annual income after 10y$7,308.86$26,227.70
Total dividends collected$44.4K$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: NTEC vs MCD ($10,000, DRIP)

YearNTEC PortfolioNTEC Income/yrMCD PortfolioMCD Income/yrGap
1$12,777$2,076.84$10,815$334.85+$2.0KNTEC
2$16,151$2,479.95$11,826$491.71+$4.3KNTEC
3$20,212$2,929.82$13,123$730.06+$7.1KNTEC
4$25,053$3,426.51$14,853$1,100.07+$10.2KNTEC
5$30,776$3,969.42$17,257$1,690.61+$13.5KNTEC
6$37,488$4,557.19$20,752$2,667.01+$16.7KNTEC
7$45,300$5,187.86$26,103$4,354.83+$19.2KNTEC
8$54,329$5,858.83$34,794$7,437.78+$19.5KNTEC
9$64,699$6,567.01$49,926$13,461.60+$14.8KNTEC
10← crossover$76,537$7,308.86$78,550$26,227.70$2.0KMCD

NTEC vs MCD: Complete Analysis 2026

NTECStock

Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.

Full NTEC Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this NTEC vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NTEC vs SCHDNTEC vs JEPINTEC vs ONTEC vs KONTEC vs MAINNTEC vs YUMNTEC vs QSRNTEC vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.